| 摘要 |
Compounds and compositions for eliciting or enhancing immune reactivity to HER-2/neu protein are disclosed. The compounds include antigen-presenting cells, such as dendritic cells, which may be used for the prevention or treatment of malignancies in which the HER-2/neu oncogene is associated. |
